Skip to main content

Advertisement

Figure 6 | Journal of Experimental & Clinical Cancer Research

Figure 6

From: Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer

Figure 6

Anti-tumor effect of Ad5MK in a Suit-2 intraperitoneal xenograft model. After intraperitoneal inoculation of 2 × 106/ml Suit-2 cells in nude mice, 2 × 109 PFU of Ad5GFP or Ad5MK, or 500 μl of PBS, was administered intraperitoneally. There was a significant difference of survival time between the Ad5MK group and the other groups (p = 0.0002 Log-rank test and p = 0.0002 by Wilcoxson's test).

Back to article page